ISRVF:OTC-iShares Public Limited Company - iShares MSCI Japan USD Hedged UCITS ETF (Acc) (USD)

ETF | Others |

Last Closing

USD 75.22

Change

0.00 (0.00)%

Market Cap

N/A

Volume

11.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

+8.48 (+1.34%)

USD 32.85B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
ETHE Grayscale Ethereum Trust (ETH)

+0.87 (+3.05%)

USD 4.89B
EBCRY EBCRY

N/A

USD 3.67B
SSEEF SSgA SPDR ETFs Europe I Public..

+0.59 (+0.82%)

USD 2.95B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B
ISRPF iShares Public Limited Company..

N/A

USD 2.22B

ETFs Containing ISRVF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.96% 81% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.96% 80% B- 75% C
Trailing 12 Months  
Capital Gain 25.96% 79% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.96% 78% C+ 74% C
Trailing 5 Years  
Capital Gain 95.24% 87% B+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 95.24% 85% B 84% B
Average Annual (5 Year Horizon)  
Capital Gain 19.76% 82% B 64% D
Dividend Return 19.76% 82% B 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.04% 53% F 92% A
Risk Adjusted Return 123.15% 100% F 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike